26 results
424B3
NTBL
Notable Labs Ltd
5 Sep 23
Prospectus supplement
6:02pm
on acceptable terms with prospective CROs and clinical trial sites;
delays in obtaining required institutional review board (“IRB”) or ethics committee
S-4/A
g6gg0vjkzcnqmno
30 Jun 23
Registration of securities issued in business combination transactions (amended)
4:38pm
S-4
03rmh926eqww22jlyrs
11 May 23
Registration of securities issued in business combination transactions
9:09am
POS AM
ahs8dbq3
19 Apr 21
Prospectus update (post-effective amendment)
5:17pm
F-1
s7vz1gagj3dwd3pncp
1 Jun 20
Registration statement (foreign)
12:18pm
424B5
dublc
12 May 20
Prospectus supplement for primary offering
12:02pm
424B5
0wzgxi6kwjrc3mw59pf
11 May 20
Prospectus supplement for primary offering
9:23am
20-F
7rii 0p8jo
25 Mar 15
Annual report (foreign)
12:00am